Time lines for the FDA seem to be under pressure
What we thought might happen looks as though it has eventuated
https://endpoints.news/kalvista-says-fda-delayed-decision-on-heart-drug-citing-heavy-workload/?utm_medium=email&utm_campaign=833%20-%20Makary%20envisions%20next%20big%20leaps%20in%20pharma%20States%20join%20Purdue%20opioid%20deal%20Basic&utm_content=833%20-%20Makary%20envisions%20next%20big%20leaps%20in%20pharma%20States%20join%20Purdue%20opioid%20deal%20Basic+CID_36ae8167a1e208cab159171c0f34c5f6&utm_source=ENDPOINTS%20emails&utm_term=KalVista%20says%20FDA%20delayed%20decision%20on%20HAE%20drug%20citing%20heavy%20workload
![]()
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
1.92%
!
$1.79

Time lines for the FDA seem to be under pressure What we thought...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.035(1.92%) |
Mkt cap ! $2.287B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $11.91M | 6.671M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 28695 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | 1.790 |
1 | 53149 | 1.785 |
6 | 82839 | 1.780 |
1 | 17489 | 1.775 |
4 | 82576 | 1.770 |
Price($) | Vol. | No. |
---|---|---|
1.800 | 28695 | 2 |
1.805 | 6652 | 2 |
1.810 | 66208 | 7 |
1.815 | 59694 | 4 |
1.820 | 25818 | 3 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online